
- This event has passed.
COCA Call – Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older
September 13, 2022 @ 2:00 pm - 3:00 pm

COCA Call – Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older
Visit the COCA website for a webinar link and more information
A few minutes before the webinar begins, please click the link below to join:
https://www.zoomgov.com/j/1619923732
Overview
During this COCA Call, presenters will discuss CDC’s new guidance on bivalent COVID-19 booster doses for people ages 12 years and older, including those who are moderately or severely immunocompromised. COVID-19 vaccination provides protection against serious illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death. Updated COVID-19 vaccines add an Omicron BA.4/5 spike protein component to the previous monovalent composition. These bivalent booster doses help restore protection that has waned since previous vaccination by targeting more transmissible and immune-evading variants. These boosters also broaden the spectrum of variants that the immune system is ready to respond to.
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
Presenters
Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Lead, COVID-19 Coordinating Unit
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Evelyn Twentyman, MD, MPH
Lead, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention